Microbial antigens mediate HLA-B27 diseases via TLRs

Journal of Autoimmunity

Volumn 32, Issue 3-4, 2009, Pages 172-177

  Pöllänen, Raimo ^a   Sillat, Tarvo ^a   Pajarinen, Jukka ^a   Levón, Jaakko ^a   Kaivosoja, Emilia ^a   Konttinen, Yrjö T ^a,b,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^c COXA Hospital for Joint Replacement ^*  (Finland)

Author keywords

Ankylosing spondylitis; HLA B27; Osteogenesis; Osteoporosis; Toll like receptor

Indexed keywords

ANNEXIN; CATHELICIDIN; DEFENSIN; ENDOTHELIN; GALECTIN; HEAT SHOCK PROTEIN; HEPATOMA DERIVED GROWTH FACTOR; HIGH MOBILITY GROUP B1 PROTEIN; HLA B27 ANTIGEN; INTERLEUKIN 1ALPHA; NUCLEOLIN; OSTEOCLAST DIFFERENTIATION FACTOR; THYMOSIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; URIC ACID;

ADAPTIVE IMMUNITY; ANKYLOSING SPONDYLITIS; ARTICLE; BONE DEVELOPMENT; CHLAMYDIA TRACHOMATIS; CHRONIC PROSTATITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DROSOPHILA MELANOGASTER; ENCHONDRAL OSSIFICATION; HUMAN; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTIVE ARTHRITIS; SALMONELLA; UROGENITAL SYSTEM;

ANTIGENS, BACTERIAL; ARTHRITIS, REACTIVE; BACTERIA; CHRONIC DISEASE; FEMALE; HLA-B27 ANTIGEN; HUMANS; MALE; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PELVIC INFLAMMATORY DISEASE; PROSTATITIS; SPONDYLITIS, ANKYLOSING; TOLL-LIKE RECEPTORS;

EID: 67349152320     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.02.010     Document Type: Article

References (48)

1. Calin A., Porta J., Fries J.F., and Schurman D.J. Clinical history as a screening test for ankylosing spondylitis. JAMA 237 (1977) 2613-2614
2. Rudwaleit M., Metter A., Listing J., Sieper J., and Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 54 (2006) 569-578
3. Van der Linden S., Valkenburg H.A., and Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27 (1984) 361-368
4. Santavirta S., Slätis P., Sandelin J., Lindqvist C., and Konttinen Y.T. Atlanto-axial subluxation in patients with seronegative spondylarthritis. Rheumatol Int 7 (1987) 43-46
5. Julkunen H., Pietilä K., and Elo J. Uro-genital infection of the male in relation to ankylosing spondylitis and rheumatoid arthritis. Acta Med Scand 19 (1966) 301-305
6. Julkunen H., and Pietilä K. Chronic salpingo-oophoritis and rheumatoid spondylitis. Acta Rheumatol Scand 10 (1964) 209-214
7. Rashid T., and Ebringer A. Ankylosing spondylitis is linked to Klebsiella - the evidence. Clin Rheumatol 26 (2007) 858-864
8. Ebringer R., Cooke D., Cawdell D.R., Cowling P., and Ebringer A. Ankylosing spondylitis: Klebsiella and HL-A B27. Rheumatol Rehabil 16 (1977) 190-196
9. Caffrey M.F., and James D.C. Human lymphocyte antigen association in ankylosing spondylitis. Nature 242 (1973) 121
10. Brewerton D.A., Hart F.D., Nicholls A., Caffrey M., James D.C., and Sturrock R.D. Ankylosing spondylitis and HL-A 27. Lancet i (1973) 904-907
11. Schlosstein L., Terasaki P.I., Bluestone R., and Pearson C.M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 288 (1973) 704-706
12. Ahvonen P., Sievers K., and Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand 15 (1969) 232-253
13. Granfors K., Jalkanen S., von Essen R., Lahesmaa-Rantala R., Isomäki O., Pekkola-Heino K., et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 320 (1989) 216-221
14. Konttinen Y.T., Nordström D., Bergroth V., Leirisalo-Repo M., and Santavirta S. Occurrence of different ensuing triggering infections preceding reactive arthritis: a follow-up study. Br Med J 296 (1988) 1644-1645
15. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., and Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 (1996) 973-983
16. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
17. Takeda K., Kaisho T., and Akira K. Toll-like receptors. Annu Rev Immunol 21 (2003) 335-376
18. Birchler T., Seibl R., Buchner K., Loeliger S., Seger R., Hossle J.P., et al. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human β-defensin 2 in response to bacterial lipoprotein. Eur J Immunol 31 (2001) 3131-3137
19. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11 (1999) 443-451
20. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413 (2001) 732-738
21. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162 (1999) 3749-3752
22. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1 (2000) 398-401
23. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410 (2001) 1099-1103
24. Takeda K., Takeuchi O., and Akira S. Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res 8 (2002) 459-463
25. Takeuchi O., Kawai T., Mühlradt P.F., Morr M., Radolf J.D., Zychlinsky A., et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 13 (2001) 933-940
26. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3 (2002) 196-200
27. Seabury C.M., and Womack J.E. Analysis of sequence variability and protein domain architectures for bovine peptidoglycan recognition protein 1 and Toll-like receptors 2 and 6. Genomics 92 (2008) 235-245
28. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
29. Chuang T.H., and Ulevitch R.J. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 1518 (2001) 157-161
30. Hasan U., Chaffois C., Gaillard C., Saulnier V., Merck E., Tancredi S., et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD881. J Immunol 174 (2005) 2942-2950
31. Tiedje J.M. Microbial diversity: of value to whom?. ASM News 60 (1994) 524-525
32. Granfors K., Jalkanen S., Lindberg A.A., Mäki-Ikola O., von Essen R., Lahesmaa-Rantala R., et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 335 (1990) 685-688
33. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81 (2007) 1-5
34. Foster S.L., Hargreaves D.C., and Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447 (2007) 972-978
35. Konttinen Y.T., Li T.-F., Lassus J., Waris V., Santavirta S., and Virtanen I. Removal of hyaline articular cartilage reduces lymphocyte infiltration and activation in rheumatoid synovial membrane. J Rheumatol 28 (2001) 2184-2189
36. Rauner M., Sipos W., and Pietschmann P. Osteoimmunology. Int Arch Allergy Immunol 143 (2007) 31-48
37. Lee S.H., Kim T.S., Choi Y., and Lorenzo J. Osteoimmunology: cytokines and the skeletal system. BMB Rep 41 (2008) 495-510
38. Gardner D.L. Reactive and postinfective arthritis and seronegative spondylarthropathy. Pathological basis of the connective tissue diseases (1992), Edward Arnold, London 763-795
39. Takami M., Kim N., Rho J., and Choi Y. Stimulation by Toll-like receptors inhibits osteoclast differentiation. J Immunol 169 (2002) 1516-1523
40. Bar-Shavit Z. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators. Autoimmunity 41 (2008) 195-203
41. Amcheslavsky A., and Bar-Shavit Z. Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides. J Cell Physiol 207 (2006) 244-250
42. Zou W., and Bar-Shavit Z. Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 17 (2002) 1211-1218
43. Zou W., Schwartz H., Endres S., Hartmann G., and Bar-Shavit Z. CpG oligonucleotides: novel regulators of osteoclast differentiation. FASEB J 16 (2002) 274-282
44. Kikuchi T., Matsuguchi T., Tsuboi N., Mitani A., Tanaka S., Matsuoka M., et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 166 (2001) 3574-3579
45. Marriott I. Osteoblast responses to bacterial pathogens. Immunol Res 30 (2004) 291-308
46. Zou W., Amcheslavsky A., and Bar-Shavit Z. CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9. J Biol Chem 278 (2003) 16732-16740
47. Cho H.H., Bae Y.C., and Jung J.S. Role of Toll-like receptors on human adipose-derived stromal cells. Stem Cells 24 (2006) 2744-2752
48. Pevsner-Fischer M., Morad V., Cohen-Sfady M., Rousso-Noori L., Zanin-Zhorov A., Cohen S., et al. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109 (2007) 1422-1432